126 related articles for article (PubMed ID: 10209295)
1. The role of the P2' position of Bowman-Birk proteinase inhibitor in the inhibition of trypsin. Studies on P2' variation in cyclic peptides encompassing the reactive site loop.
Gariani T; McBride JD; Leatherbarrow RJ
Biochim Biophys Acta; 1999 Apr; 1431(1):232-7. PubMed ID: 10209295
[TBL] [Abstract][Full Text] [Related]
2. Stability of protease inhibitors based on the Bowman-Birk reactive site loop to hydrolysis by proteases.
Gariani T; Leatherbarrow RJ
J Pept Res; 1997 Jun; 49(6):467-75. PubMed ID: 9266473
[TBL] [Abstract][Full Text] [Related]
3. The role of threonine in the P2 position of Bowman-Birk proteinase inhibitors: studies on P2 variation in cyclic peptides encompassing the reactive site loop.
McBride JD; Brauer AB; Nievo M; Leatherbarrow RJ
J Mol Biol; 1998 Sep; 282(2):447-58. PubMed ID: 9735299
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of a mixture of cyclic peptides based on the Bowman-Birk reactive site loop to screen for serine protease inhibitors.
Domingo GJ; Leatherbarrow RJ; Freeman N; Patel S; Weir M
Int J Pept Protein Res; 1995 Jul; 46(1):79-87. PubMed ID: 7558601
[TBL] [Abstract][Full Text] [Related]
5. Synthetic peptide mimics of the Bowman-Birk inhibitor protein.
McBride JD; Leatherbarrow RJ
Curr Med Chem; 2001 Jul; 8(8):909-17. PubMed ID: 11375759
[TBL] [Abstract][Full Text] [Related]
6. Selection of chymotrypsin inhibitors from a conformationally-constrained combinatorial peptide library.
McBride JD; Freeman N; Domingo GJ; Leatherbarrow RJ
J Mol Biol; 1996 Jun; 259(4):819-27. PubMed ID: 8683585
[TBL] [Abstract][Full Text] [Related]
7. The conserved P1' Ser of Bowman-Birk-type proteinase inhibitors is not essential for the integrity of the reactive site loop.
Brauer AB; Leatherbarrow RJ
Biochem Biophys Res Commun; 2003 Aug; 308(2):300-5. PubMed ID: 12901868
[TBL] [Abstract][Full Text] [Related]
8. Primary structure of Dioclea glabra trypsin inhibitor, DgTI, a Bowman-Birk inhibitor.
Bueno NR; Fritz H; Auerswald EA; Mentele R; Sampaio M; Sampaio CA; Oliva ML
Biochem Biophys Res Commun; 1999 Aug; 261(3):838-43. PubMed ID: 10441512
[TBL] [Abstract][Full Text] [Related]
9. Complete amino acid sequence of the lentil trypsin-chymotrypsin inhibitor LCI-1.7 and a discussion of atypical binding sites of Bowman-Birk inhibitors.
Weder JK; Hinkers SC
J Agric Food Chem; 2004 Jun; 52(13):4219-26. PubMed ID: 15212472
[TBL] [Abstract][Full Text] [Related]
10. Peptide mimics of the Bowman-Birk inhibitor reactive site loop.
McBride JD; Watson EM; Brauer AB; Jaulent AM; Leatherbarrow RJ
Biopolymers; 2002; 66(2):79-92. PubMed ID: 12325158
[TBL] [Abstract][Full Text] [Related]
11. Studies on the synthesis of proteinase inhibitors. II. Synthesis of cyclic nonapeptide fragments and analogs related to the reactive sites of soybean Bowman-Birk inhibitor.
Terada S; Sato K; Kato T; Izumiya N
Int J Pept Protein Res; 1980 May; 15(5):441-54. PubMed ID: 7440053
[TBL] [Abstract][Full Text] [Related]
12. On a Bowman-Birk family proteinase inhibitor from Erythrina variegata seeds.
Kimura M; Kouzuma Y; Abe K; Yamasaki N
J Biochem; 1994 Mar; 115(3):369-72. PubMed ID: 8056744
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and analysis of novel bicyclic and bifunctional protease inhibitors.
Jaulent AM; Leatherbarrow RJ
Protein Eng Des Sel; 2004 Sep; 17(9):681-7. PubMed ID: 15486024
[TBL] [Abstract][Full Text] [Related]
14. The (1)H-NMR solution structure of the antitryptic core peptide of Bowman-Birk inhibitor proteins: a minimal canonical loop.
Brauer AB; Kelly G; Matthews SJ; Leatherbarrow RJ
J Biomol Struct Dyn; 2002 Aug; 20(1):59-70. PubMed ID: 12144352
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the P2' and P3' specificities of thrombin using fluorescence-quenched substrates and mapping of the subsites by mutagenesis.
Le Bonniec BF; Myles T; Johnson T; Knight CG; Tapparelli C; Stone SR
Biochemistry; 1996 Jun; 35(22):7114-22. PubMed ID: 8679538
[TBL] [Abstract][Full Text] [Related]
16. Reactive sites of an anticarcinogenic Bowman-Birk proteinase inhibitor are similar to other trypsin inhibitors.
Chen P; Rose J; Love R; Wei CH; Wang BC
J Biol Chem; 1992 Jan; 267(3):1990-4. PubMed ID: 1730730
[TBL] [Abstract][Full Text] [Related]
17. Identification of chymotrypsin inhibitors from a second-generation template assisted combinatorial peptide library.
McBride JD; Freeman HN; Leatherbarrow RJ
J Pept Sci; 2000 Sep; 6(9):446-52. PubMed ID: 11016881
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and bio-assay of RCM-derived Bowman-Birk inhibitor analogues.
Miles SM; Leatherbarrow RJ; Marsden SP; Coates WJ
Org Biomol Chem; 2004 Feb; 2(3):281-3. PubMed ID: 14747852
[TBL] [Abstract][Full Text] [Related]
19. Studies on the synthesis of proteinase inhibitors. I. Synthesis and activity of nonapeptide fragments of soybean Bowman-Birk inhibitor.
Nishino N; Aoyagi H; Kato T; Izumiya N
J Biochem; 1977 Sep; 82(3):901-9. PubMed ID: 914812
[TBL] [Abstract][Full Text] [Related]
20. Identification and Target-Modification of SL-BBI: A Novel Bowman-Birk Type Trypsin Inhibitor from
Chen X; Chen D; Huang L; Chen X; Zhou M; Xi X; Ma C; Chen T; Wang L
Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32872343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
